Research and development at the Centre of Excellence for Dermatology

The research and development (R&D) of dermatological drugs is of pivotal importance for the Centre of Excellence for Dermatology. The internationally aligned functional divisions of Pharmaceutical Development (PD), Global Clinical Development (GCD) and International Regulatory Affairs (IREG) of Almirall in Reinbek work closely with the Operations division and the Global Marketing Dermatology division, which are also located at the site. This constellation facilitates the development of high-quality and efficient dermatological drugs by ensuring that legal guidelines as well as requirements of the market, healthcare professionals and patients are taken into consideration at an early stage. The company's own project management team coordinates and manages the entire R&D activities in order to ultimately expand the demanding product pipeline continually with innovative dermatological drugs.
Genuair	®
GenuairŪ
Therepeutic efficacy favoured by a safe and easy to use administration

Genuair is a registered trademark of Almirall, S.A.. It is the proposed trademark for the MDPI and is pending regulatory approval.

Almirall Sofotec

Healthcare professionals
Healthcare professionals
Access for doctors and pharmacists

Healthcare professionals access

Dermatologist
Dermatologist search
Find dermatologists near you

Start dermatologist search

Encyclopaedia
Encyclopaedia
This comprehensive work includes the entire diagnosis and therapy of the specialist areas of dermatology

Open encyclopaedia